The Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market would witness market growth of 5.9% CAGR during the forecast period (2022-2028).
CRT is used to treat patients who have aberrant electrical and mechanical activation, which leads to increased cardiac inefficiency and performance. On an ECG, aberrant electrical activation is indicated by a prolonged QRS duration and, in most cases, left bundle branch block. Desynchrony is an abnormal activation pattern that can be intraventricular, interventricular, or atrioventricular. CRT's atrial synchronized pacing from the right and left ventricles allows this cardiac desynchrony to be corrected and cardiac function to be improved. With the rising number of people with cardiac disorders and illnesses, the demand for congestive heart failure treatment devices is estimated to spur in the coming years.
Many ICDs and CRTs have built-in technologies that allow the doctor or nurse to monitor patients' heart function, heart rhythm, and amount of exercise. In addition, the patient may need to use a personal digital assistant to convey information to their healthcare physician. The modern internal monitoring device (CardioMEMS) is as small as a paperclip. It is implanted in a blood vessel near the heart to monitor blood vessel and left ventricular pressure. The data is transmitted to a computer server. The healthcare practitioner utilizes the data from the device to make sure that the patient is receiving the optimum therapy for the disease and to determine if they need to modify anything about their medication, food, or amount of activity.
Over the past few years, China has witnessed significant and fundamental transformations. As a result of lifestyle modifications, urbanization, and the hastened aging process, China is experiencing cardiovascular disease (CVD) crisis. CVDs are on the rise and will continue to do so during the next few years. Since 2005, the Chinese National Center for Cardiovascular Diseases has brought together experts in cardiology, nephrology, neurology, diabetes, epidemiology, health economics, biostatistics, and other domains to write the annual Report on Cardiovascular Diseases in China. The goal of the study is to give a timely analysis of the expanding CVD outbreaks as well as an assessment of CVD prevention and control measures. A summary of the Report on Cardiovascular Diseases in China 2015 is provided, which contains trends in CVD, CVD morbidity and mortality, risk factors evaluation, CVD health resources, and a medical cost profile.
The China market dominated the Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,300.2 Million by 2028. The Japan market is estimated to grow at a CAGR of 5.3% during (2022 - 2028). Additionally, The India market would witness a CAGR of 6.6% during (2022 - 2028).
Based on Product Type, the market is segmented into Pacemakers, Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy, and Ventricular Assist Devices. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Congestive Heart Failure (CHF) Treatment Devices Market is Projected to reach USD 16.5 Billion by 2028, at a CAGR of 5.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, MicroPort Scientific Corporation, Abbott Laboratories, Medtronic PLC, Abiomed, Inc., Berlin Heart GmbH, Jarvik Heart, Inc., Lepu Medical Technology (Beijing) Co., Ltd., BIOTRONIK SE & Co. KG, and Osypka Medical GmbH.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Pacemakers
- Implantable Cardioverter Defibrillators
- Cardiac Resynchronization Therapy
- Ventricular Assist Devices
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Abbott Laboratories
- Medtronic PLC
- Abiomed, Inc.
- Berlin Heart GmbH
- Jarvik Heart, Inc.
- Lepu Medical Technology (Beijing) Co., Ltd.
- BIOTRONIK SE & Co. KG
- Osypka Medical GmbH
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market, by Product Type
1.4.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players
Chapter 4. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
4.1 Asia Pacific Pacemakers Market by Country
4.2 Asia Pacific Implantable Cardioverter Defibrillators Market by Country
4.3 Asia Pacific Cardiac Resynchronization Therapy Market by Country
4.4 Asia Pacific Ventricular Assist Devices Market by Country
Chapter 5. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Country
5.1 China Congestive Heart Failure (CHF) Treatment Devices Market
5.1.1 China Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2 Japan Congestive Heart Failure (CHF) Treatment Devices Market
5.2.1 Japan Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3 India Congestive Heart Failure (CHF) Treatment Devices Market
5.3.1 India Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4 South Korea Congestive Heart Failure (CHF) Treatment Devices Market
5.4.1 South Korea Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.5 Singapore Congestive Heart Failure (CHF) Treatment Devices Market
5.5.1 Singapore Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.6 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market
5.6.1 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.7 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market
5.7.1 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Product Launches and Product Expansions:
6.1.5.3 Acquisition and Mergers:
6.2 MicroPort Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent Strategies and Developments:
6.2.5.1 Approvals and Trials:
6.2.5.2 Product launches and Product Expansions:
6.3 Abbott Laboratories
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Approvals and Trials:
6.3.5.3 Acquisitions and Mergers:
6.3.5.4 Product Launches and Product Expansions:
6.4 Medtronic PLC
6.4.1 Company overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 Abiomed, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Approvals and Trials:
6.5.5.2 Acquisition and Mergers:
6.6 Berlin Heart GmbH
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Partnerships, Collaborations, and Agreements:
6.7 Jarvik Heart, Inc.
6.7.1 Company Overview
6.8 Lepu Medical Technology (Beijing) Co., Ltd.
6.8.1 Company Overview
6.9 BIOTRONIK SE & Co. KG
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations and Agreements:
6.9.2.2 Approvals & Trials:
6.9.2.3 Product Launches and Product Expansions:
6.10. Osypka Medical GmbH
6.10.1 Company Overview
TABLE 1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 4 Product Launches And Product Expansions– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 5 Acquisition and Mergers– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 6 Approvals and Trials - Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 7 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Pacemakers Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Pacemakers Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Implantable Cardioverter Defibrillators Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Implantable Cardioverter Defibrillators Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Cardiac Resynchronization Therapy Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Cardiac Resynchronization Therapy Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Ventricular Assist Devices Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Ventricular Assist Devices Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2022 - 2028, USD Million
TABLE 19 China Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 20 China Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 21 China Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 22 China Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 23 Japan Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 24 Japan Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 25 Japan Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 26 Japan Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 27 India Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 28 India Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 29 India Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 30 India Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 31 South Korea Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 32 South Korea Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 33 South Korea Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 34 South Korea Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 35 Singapore Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 36 Singapore Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 37 Singapore Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 38 Singapore Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 39 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 40 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 41 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 42 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 43 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 44 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 45 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 46 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 47 key Information – Boston Scientific Corporation
TABLE 48 key Information – MicroPort Scientific Corporation
TABLE 49 Key Information – Abbott Laboratories
TABLE 50 Key Information – Medtronic PLC
TABLE 51 Key Information – ABIOMED, Inc.
TABLE 52 Key Information – Berlin Heart GmbH
TABLE 53 Key Information – JARVIK HEART, INC.
TABLE 54 Key Information – Lepu Medical Technology (Beijing) Co., Ltd.
TABLE 55 Key Information – BIOTRONIK SE & Co. KG
TABLE 56 Key Information – Osypka Medical GmbH
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players
FIG 5 Recent strategies and developments: Boston Scientific Corporation
FIG 6 Recent Strategies and Developments: MicroPort Scientific Corporation
FIG 7 Recent strategies and developments: Abbott Laboratories
FIG 8 Recent strategies and developments: Abiomed, Inc.